SCHEMBL8261399

SCHEMBL8261399

C[C@H](c1ccccc1)N1CC[C@@](O)(c2ccc(OCc3ccccc3)cc2)[C@H](O)C1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CHRM4 P08173 1/20 0.47
▸ OPRL1 P41146 4/20 0.44
▸ OPRM1 P35372 3/20 0.44
▸ OPRD1 P41143 2/20 0.44
▸ OPRK1 P41145 2/20 0.44
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ MMP2 P08253 1/20 0.43
▸ MMP9 P14780 1/20 0.43
▸ ADAM17 P78536 1/20 0.43
▸ CCR1 P32246 1/20 0.41
▸ ALOX5 P09917 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ HRH3 Q9Y5N1 1/20 0.39
▸ CCR5 P51681 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4602613 0.82 OPRL1 (0.67) CHRM4OPRL1OPRM1OPRD1OPRK1
SCHEMBL4602609 0.82 OPRL1 (0.67) CHRM4OPRL1OPRM1OPRD1OPRK1
SCHEMBL7974951 0.80 CHRM4 (0.46) CHRM4OPRL1OPRM1OPRD1OPRK1
SCHEMBL6623585 0.80 CHRM4 (0.46) CHRM4OPRL1OPRM1OPRD1OPRK1
SCHEMBL8186450 0.79 NPC1 (0.56) OPRL1NPC1RAB9AMMP9ADAM17
SCHEMBL8186451 0.79 NPC1 (0.56) OPRL1NPC1RAB9AMMP9ADAM17
SCHEMBL8195224 0.78 HRH3 (0.54) OPRM1OPRD1OPRK1NPC1RAB9A
SCHEMBL8195157 0.78 HRH3 (0.54) OPRM1OPRD1OPRK1NPC1RAB9A
SCHEMBL6625512 0.75 CHRM4 (0.54) CHRM4NPC1RAB9AALOX5MAPK1
SCHEMBL4602232 0.75 CHRM4 (0.54) CHRM4NPC1RAB9AALOX5MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000063173-A1 PROCESS FOR THE PREPARATION OF SUBSTITUTED PIPERIDINES F. HOFFMANN-LA ROCHE AG (CH) 2000-10-26 — — WO disclosed
Send feedback